These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38680420)
1. Torsades de Pointe Associated with Trazodone Consumption. Khederlou H; Azimi Pirsaraei V Case Rep Crit Care; 2024; 2024():5759229. PubMed ID: 38680420 [TBL] [Abstract][Full Text] [Related]
2. Trazodone Overdose Manifesting as Hypotension and QT Prolongation. Mohan G; Ajitkumar A; Bhide P; Ravilla J; Kramer V Cureus; 2023 Mar; 15(3):e36871. PubMed ID: 37123743 [TBL] [Abstract][Full Text] [Related]
3. QTc Prolongation in Poison Center Exposures to CredibleMeds List of Substances with "Known Risk of Torsades de Pointes". Ryan K; Benz P; Zosel A; Farkas A; Theobald J Cardiovasc Toxicol; 2022 Sep; 22(9):866-877. PubMed ID: 35930218 [TBL] [Abstract][Full Text] [Related]
4. QT prolongation, torsades des pointes, and cardiac arrest after 4 mg of IV ondansetron. Orozco BS; Lee SC; Fuchs RT; Fushianes GD; Cole JB Am J Emerg Med; 2023 Jun; 68():214.e3-214.e6. PubMed ID: 37085406 [TBL] [Abstract][Full Text] [Related]
5. Arrhythmias in Severe Trazodone Overdose. Soe KK; Lee MY Am J Case Rep; 2019 Dec; 20():1949-1955. PubMed ID: 31879415 [TBL] [Abstract][Full Text] [Related]
6. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938 [TBL] [Abstract][Full Text] [Related]
7. Increased ventricular ectopy precedes Torsades de Pointes in patients with prolonged QT. Marill KA; Lopez S; Hark D; Spahr J; Kapadia N; Liu SW J Electrocardiol; 2023; 80():17-23. PubMed ID: 37105125 [TBL] [Abstract][Full Text] [Related]
8. Electrocardiographic measures of repolarization heterogeneity are not predictive for Torsades de Pointes among undifferentiated patients with prolonged QTc: A case control study. Marill KA; Lopez S; Hark D; Spahr J; Shesh-Muthal K; Xue J; Rowlandson GI; Liu SW J Cardiovasc Electrophysiol; 2023 Jan; 34(1):166-176. PubMed ID: 36335640 [TBL] [Abstract][Full Text] [Related]
9. QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter-defibrillator: Case report and review of the literature. Wei A; Peng J; Gu Z; Li J Medicine (Baltimore); 2017 Dec; 96(49):e9071. PubMed ID: 29245320 [TBL] [Abstract][Full Text] [Related]
10. Prevalence, therapeutic response, and outcome of ventricular tachycardia in the out-of-hospital setting: a comparison of monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, and torsades de pointes. Brady WJ; DeBehnke DJ; Laundrie D Acad Emerg Med; 1999 Jun; 6(6):609-17. PubMed ID: 10386678 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US. Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851 [TBL] [Abstract][Full Text] [Related]
12. Prolonged QTc interval due to escitalopram overdose. Mohammed R; Norton J; Geraci SA; Newman DB; Koch CA J Miss State Med Assoc; 2010 Dec; 51(12):350-3. PubMed ID: 21370605 [TBL] [Abstract][Full Text] [Related]
13. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs). Lu HR; Yan GX; Gallacher DJ J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247 [TBL] [Abstract][Full Text] [Related]
14. Torsades de pointes episode in a woman with high-grade fever and inflammatory activation: A case report. Qiu H; Li HW; Zhang SH; Zhou XG; Li WP World J Clin Cases; 2021 Apr; 9(12):2899-2907. PubMed ID: 33969075 [TBL] [Abstract][Full Text] [Related]
15. Donepezil-induced torsades de pointes without QT prolongation. Hadano Y; Ogawa H; Wakeyama T; Iwami T; Kimura M; Mochizuki M; Akashi S; Miyazaki Y; Nakashima T; Shimizu A J Cardiol Cases; 2013 Aug; 8(2):e69-e71. PubMed ID: 30546746 [TBL] [Abstract][Full Text] [Related]
16. Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest. Tarabar AF; Hoffman RS; Nelson L J Med Toxicol; 2008 Jun; 4(2):101-5. PubMed ID: 18570170 [TBL] [Abstract][Full Text] [Related]
17. Personalized, intuitive & visual QT-prolongation monitoring using patient-specific QTc threshold with pseudo-coloring and explainable AI. Alahmadi A; Davies A; Vigo M; Jay C J Electrocardiol; 2023; 81():218-223. PubMed ID: 37837739 [TBL] [Abstract][Full Text] [Related]
18. Acquired Long QT Syndrome: Ventricular Fibrillation in an Otherwise Healthy Young Female. Ott WP; Bellamy SE; Khan M; Shahid A; Javed MT Cureus; 2023 Apr; 15(4):e37263. PubMed ID: 37162788 [TBL] [Abstract][Full Text] [Related]
19. Drug-induced QT Interval Prolongation in the Intensive Care Unit. Etchegoyen CV; Keller GA; Mrad S; Cheng S; Di Girolamo G Curr Clin Pharmacol; 2017; 12(4):210-222. PubMed ID: 29473523 [TBL] [Abstract][Full Text] [Related]
20. An explainable algorithm for detecting drug-induced QT-prolongation at risk of torsades de pointes (TdP) regardless of heart rate and T-wave morphology. Alahmadi A; Davies A; Royle J; Goodwin L; Cresswell K; Arain Z; Vigo M; Jay C Comput Biol Med; 2021 Apr; 131():104281. PubMed ID: 33636421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]